Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
65,459.64 -1,281.94 (-1.92%) CMC Crypto 200
1,377.71 -40.16 (-2.84%)
BMY Oct 2024 48.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
| Previous close | 1.0000 |
| Open | 0.5400 |
| Bid | 0.6800 |
| Ask | 0.7400 |
| Strike | 48.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.5300 - 0.5400 |
| Contract range | N/A |
| Volume | |
| Open interest | 750 |
Business WireU.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
PRINCETON, N.J., June 13, 2024--U.S. FDA Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive....
ZacksBristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ZacksBristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Bristol Myers Squibb (BMY) reachead $43.02 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.
© 2024 Yahoo. All rights reserved.